You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KYMR Award Disclosure
Rooney Terence · SEC Form 4 · Filed Jul 27, 2026
Award
Calculated transaction value
$0
Rooney Terence Chief Medical Officer
KYMR
Kymera Therapeutics
KYMR
Transaction date
Jul 27, 2026
Public filing date
Jul 27, 2026
Filing lag
Filed same day
KYMR daily price context
Close on/before transaction
$110.05
Jul 27, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 76,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-318408
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kymera Therapeutics, Inc. KYMR Current | Award | Jul 27, 2026 | $0 |
| Kymera Therapeutics, Inc. KYMR | Award | Jul 27, 2026 | $0 |